1. Aarskog–Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?. (1st February 2022) Authors: Calabrese, G.; Licata, G.; Buononato, D.; Gambardella, A.; De Rosa, A.; Argenziano, G. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 2(2022) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aarskog–Scott syndrome and atopic dermatitis successfully treated with dupilumab: a casual presentation?. (27th October 2021) Authors: Calabrese, G.; Licata, G.; Buononato, D.; Gambardella, A.; De Rosa, A.; Argenziano, G. Journal: Clinical and experimental dermatology Issue: Volume 47:Number 2(2022) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical improvement of atopic dermatitis in two patients co‐affected with non‐severe COVID‐19 infection: A case series and review of literature. (3rd February 2022) Authors: Licata, G.; Buononato, D.; Fiorentino, C.; Calabrese, G.; De Rosa, A.; Argenziano, G.; Gambardella, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 5(2022) Page Start: e339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dupilumab and conjunctivitis: a case series of twenty patients. (11th June 2021) Authors: Calabrese, G.; Gambardella, A.; Licata, G.; Di Brizzi, E.V.; Alfano, R.; Argenziano, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 9(2021) Page Start: e612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy, safety and patient's satisfaction for treatment of genital psoriasis with tildrakizumab: a case series and review of literature. (4th July 2022) Authors: Licata, G.; Danzuso, G.C.L.; Fiorella, C.; Palazzo, G.; Calzavara‐Pinton, P.; Argenziano, G.; Gambardella, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: e916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib. (30th September 2021) Authors: Licata, G.; Gambardella, A.; Tancredi, V.; Calabrese, G.; De Rosa, A.; Alfano, R.; Argenziano, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Is itching in atopic dermatitis still an unmet need? A case series of 556 patients. (8th April 2022) Authors: Tancredi, V.; Licata, G.; Calabrese, G.; Gambardella, A.; De Rosa, A.; Alfano, R.; Argenziano, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 8(2022) Page Start: e650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Metabolic and anti‐inflammatory effects of a home‐based programme of aerobic physical exercise. Issue 12 (December 2013) Authors: Di Raimondo, D.; Tuttolomondo, A.; Buttà, C.; Casuccio, A.; Giarrusso, L.; Miceli, G.; Licata, G.; Pinto, A. Journal: International journal of clinical practice Issue: Volume 67:Issue 12(2013) Page Start: 1247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. (14th July 2021) Authors: Licata, G.; Gambardella, A.; Calabrese, G.; Pagliuca, F.; Alfano, R.; Argenziano, G. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Refractory Type I pityriasis rubra pilaris treated with tildrakizumab. (1st December 2021) Authors: Licata, G.; Gambardella, A.; Calabrese, G.; Pagliuca, F.; Alfano, R.; Argenziano, G. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗